Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Analysts
Analyst ratings and price targets
Past year Each firm's latest target, newest first
Each firm's latest price target on ANGO, newest first
Firm
Rating
Target
Action
Date
H.C. Wainwright
Buy
$18
Cut from $19
Canaccord
Buy
$20
Target set
Each firm's latest target from the past year, with the rating stated with its note. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice.
Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 9, 2026.
Proxy statementas filed for fiscal 2026 · proxy filed Oct 8, 2026
Executive pay
James C. Clemmer’s pay as CEO came to $6.1M for fiscal 2026.
Executive
Salary
Stock awards
Other
Total
James C. ClemmerPresident, CEO
$828K
$3.7M
$1.5M
$6.1M
Stephen A. TrowbridgeEVP, CFO
$471K
$1.6M
$634K
$2.7M
Laura PiccininiSVP & GM, Cardiovascular and International
$471K
$580K
$558K
$1.6M
Lawrence T. WeissSVP, Chief Legal Officer & Corporate Secretary
$439K
$553K
$502K
$1.5M
Warren NighanSVP & GM, Global Supply Chain, Quality and Regulatory Affairs
$416K
$525K
$490K
$1.4M
The summary compensation table from the proxy statement for fiscal 2026, with titles as filed then. Executives who have since left are not shown. Read the filing
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
STOCK Act5 disclosures of 5 on record · median 28d of the 45 allowed
Congress trades in ANGO
Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
-5.6%since the tradeEstimated entry price $12.42, close on Wed Apr 27, 2016Current price $11.73, close on Fri Nov 6
Apr 27, 2016
Jul 6, 2016
70d
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.